Generali Investments CEE’s Sarepta Therapeutics SRPT Stock Holding History

Generali Investments CEE’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.81M	Buy	211,850 +48,560	+30%	+$918K	0.18%	141
2026 Q1	$3.55M	Buy	163,290 +26,828	+20%	+$519K	0.19%	148
2025 Q4	$2.94M	Buy	136,462 +12,813	+10%	+$270K	0.21%	154
2025 Q3	$2.38M	Buy	123,649 +18,323	+17%	+$327K	0.18%	151
2025 Q2	$1.8M	Buy	105,326 +103,326	+5,166%	+$4.41M	0.15%	177
2025 Q1	$128K	Hold	2,000	–	–	0.01%	350
2024 Q4	$243K	Buy	+2,000	New	+$245K	0.03%	296

Other funds holding SRPT

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

CGC Financial Services Lake Oswego, Oregon $445M AUM 17.73% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return